https://openbell.ai/ 2026-10-07T14:52:43.099Z hourly 1.0 https://openbell.ai/support 2026-10-07T14:52:43.099Z monthly 0.7 https://openbell.ai/privacy 2026-10-07T14:52:43.099Z monthly 0.5 https://openbell.ai/terms 2026-10-07T14:52:43.099Z monthly 0.5 https://openbell.ai/feed.json 2026-10-07T14:52:43.099Z hourly 0.8 https://openbell.ai/news/ICE:1791384621483 2026-10-07T14:50:21.483Z daily 0.9 https://cdn.brandfetch.io/ICE/w/400/h/400?c=1idopYfmtR7ZKg8QMud Barclays Maintains Overweight on Intercontinental Exchange, Raises Price Target to $189 Barclays analyst Benjamin Budish has maintained an Overweight rating on Intercontinental Exchange (NYSE: ICE) and increased the price target from $182 to $189. This adjustment reflects a positive outlook on the company's performance. https://openbell.ai/news/IBKR:1791384532313 2026-10-07T14:48:52.313Z daily 0.9 https://cdn.brandfetch.io/IBKR/w/400/h/400?c=1idopYfmtR7ZKg8QMud Barclays Maintains Overweight on Interactive Brokers Group, Raises Price Target to $115 Barclays analyst Benjamin Budish has maintained an Overweight rating on Interactive Brokers Group (NASDAQ: IBKR) and increased the price target from $114 to $115. This adjustment reflects a positive outlook for the company in the market. https://openbell.ai/news/LPCN:1791384257498 2026-10-07T14:44:17.498Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/07/Healthcare-Costs-Fuel-BNPL-Growth.jpg?width=250&height=187 Canadian Approval Of Lipocine Drug Marks Progress for Oral Testosterone Options In Canada Health Canada has approved Lipocine Inc.'s TLANDO (testosterone undecanoate) capsules for use as testosterone replacement therapy in adult males with testosterone deficiency. Verity Pharmaceuticals, which holds exclusive commercial rights for TLANDO in North America, plans to launch the product in Canada by the end of 2026. The Canadian TRT market presents a significant opportunity, with over 700,000 prescriptions written annually, and Lipocine aims to capture market share with TLANDO's oral formulation, which offers convenience over traditional injection and gel methods. Following the approval, Lipocine's stock rose 15.72% to $2.43. https://openbell.ai/news/FMS:1791384129149 2026-10-07T14:42:09.149Z daily 0.9 https://cdn.brandfetch.io/FMS/w/400/h/400?c=1idopYfmtR7ZKg8QMud Fresenius Medical Care Shares Halted, News Pending openbell Financial News https://openbell.ai/news/SGML:1791384119311 2026-10-07T14:41:59.311Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/07/Mining-Engineer-Overlooking-Open-Pit-Qua.jpg?width=250&height=187 Sigma Lithium Resumes Operations Following Brazilian Federal Court Ruling Sigma Lithium Corporation (NASDAQ: SGML) has resumed its mining operations following a ruling by Brazil's Federal Court of Appeals that reinstated its environmental licenses. The decision allows the company to maintain its production guidance of 330,000 tonnes of lithium oxide concentrate annually by the end of 2027. Sigma's shares rose 3.09% to $10.01 after the announcement, reflecting positive market sentiment regarding the resumption of operations. https://openbell.ai/news/LLY:1791384013985 2026-10-07T14:40:13.985Z daily 0.9 https://cdn.brandfetch.io/LLY/w/400/h/400?c=1idopYfmtR7ZKg8QMud Eli Lilly shares are trading higher. Morgan Stanley maintained its Overweight rating on the stock and raised its price target from $1419 to $1430. openbell Financial News https://openbell.ai/news/SNX:1791383796188 2026-10-07T14:36:36.188Z daily 0.9 https://cdn.brandfetch.io/SNX/w/400/h/400?c=1idopYfmtR7ZKg8QMud TD Synnex Enters Into A Definitive Agreement to Acquire BlueStar; No Terms Disclosed TD SYNNEX (NYSE: SNX) has entered into a definitive agreement to acquire BlueStar, a specialty distributor known for its expertise in various technologies including AIDC and RFID. The transaction is pending customary regulatory approvals and aims to enhance technology offerings and support for customers and vendors. Both companies will continue to operate independently until the deal is finalized, and they are committed to supporting their partners during the review process. https://openbell.ai/news/GH:1791383630490 2026-10-07T14:33:50.490Z daily 0.9 https://cdn.brandfetch.io/GH/w/400/h/400?c=1idopYfmtR7ZKg8QMud Barclays Maintains Overweight on Guardant Health, Raises Price Target to $220 Barclays analyst Luke Sergott has maintained an Overweight rating on Guardant Health (NASDAQ: GH) and increased the price target from $200 to $220. This adjustment reflects a positive outlook on the company's performance. https://openbell.ai/news/LLY:1791383513096 2026-10-07T14:31:53.096Z daily 0.9 https://cdn.brandfetch.io/LLY/w/400/h/400?c=1idopYfmtR7ZKg8QMud Morgan Stanley Maintains Overweight on Eli Lilly, Raises Price Target to $1430 Morgan Stanley analyst Terence Flynn has maintained an Overweight rating on Eli Lilly (NYSE: LLY) and increased the price target from $1419 to $1430. This adjustment reflects positive sentiment towards the company's performance and future prospects. https://openbell.ai/news/USO:1791383474453 2026-10-07T14:31:14.453Z daily 0.9 https://cdn.brandfetch.io/USO/w/400/h/400?c=1idopYfmtR7ZKg8QMud USA Gasoline Inventories 0.382M Barrel Build Vs 1.700M Barrel Draw Est. openbell Financial News https://openbell.ai/news/USO:1791383433654 2026-10-07T14:30:33.654Z daily 0.9 https://cdn.brandfetch.io/USO/w/400/h/400?c=1idopYfmtR7ZKg8QMud USA Crude Oil Inventories 3.186M Barrel Draw Vs 1.900M Barrel Draw Est. openbell Financial News https://openbell.ai/news/TSLA:1791383427164 2026-10-07T14:30:27.164Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/07/Elon-Musk-Is-A-Businessman-Known-For-His.jpg?width=250&height=187 Tesla Pressured European Regulators to Ease FSD Review As Musk Claimed Delays 'Cost Lives': Reuters Tesla Inc. has been pressuring European regulators, particularly the Dutch regulator RDW, to expedite the approval of its Full Self-Driving (FSD) system, arguing that delays could lead to loss of life. The RDW has approved FSD Supervised in April, allowing Tesla to pursue broader EU approval, while Tesla has disputed regulatory costs and requested less intensive reviews. Despite claims of safety benefits, independent experts have raised concerns about the validity of Tesla's safety data, and the FSD Supervised system still requires driver intervention. Tesla shares fell approximately 1.3% to $375 in early trading. https://openbell.ai/news/QXO:1791383408075 2026-10-07T14:30:08.075Z daily 0.9 https://cdn.brandfetch.io/QXO/w/400/h/400?c=1idopYfmtR7ZKg8QMud QXO shares are trading lower after RBC Capital lowered its price target from $27 to $18. openbell Financial News https://openbell.ai/news/SPY:1791383296507 2026-10-07T14:28:16.507Z daily 0.9 https://cdn.brandfetch.io/SPY/w/400/h/400?c=1idopYfmtR7ZKg8QMud Major indices are trading lower as climbing oil prices and rising 10-year Treasury yields hit their highest level since 2002. This benchmark raises inflation concerns and expectations of future rate hikes. openbell Financial News https://openbell.ai/news/EQH:1791383287522 2026-10-07T14:28:07.522Z daily 0.9 https://cdn.brandfetch.io/EQH/w/400/h/400?c=1idopYfmtR7ZKg8QMud Barclays Maintains Overweight on Equitable Holdings, Raises Price Target to $61 Barclays analyst Alex Scott has maintained an Overweight rating on Equitable Holdings (NYSE: EQH) and increased the price target from $52 to $61. This adjustment reflects a positive outlook for the company's performance in the market. https://openbell.ai/news/MRVL:1791383230426 2026-10-07T14:27:10.426Z daily 0.9 https://cdn.brandfetch.io/MRVL/w/400/h/400?c=1idopYfmtR7ZKg8QMud Marvell CEO Matt Murphy, On CNBC, Says Implied Data Center Revenue Could Top $30B By FY28 Marvell Technology's CEO, Matt Murphy, stated in a CNBC interview that the company's implied data center revenue could exceed $30 billion by fiscal year 2028. This projection highlights the company's growth potential in the data center market. The stock ticker for Marvell is MRVL. https://openbell.ai/news/VIR:1791382898362 2026-10-07T14:21:38.362Z daily 0.9 https://cdn.brandfetch.io/VIR/w/400/h/400?c=1idopYfmtR7ZKg8QMud HC Wainwright & Co. Maintains Buy on Vir Biotechnology, Raises Price Target to $22 HC Wainwright & Co. analyst Patrick R. Trucchio has maintained a Buy rating on Vir Biotechnology (NASDAQ: VIR) and raised the price target from $20 to $22. This adjustment reflects a positive outlook for the company's performance. https://openbell.ai/news/ABBV:1791382818034 2026-10-07T14:20:18.034Z daily 0.9 https://cdn.brandfetch.io/ABBV/w/400/h/400?c=1idopYfmtR7ZKg8QMud Morgan Stanley Maintains Overweight on AbbVie, Raises Price Target to $310 Morgan Stanley analyst Terence Flynn has maintained an Overweight rating on AbbVie (NYSE: ABBV) and increased the price target from $296 to $310. This adjustment reflects a positive outlook for the company's performance in the market. https://openbell.ai/news/ELV:1791382548473 2026-10-07T14:15:48.473Z daily 0.9 https://cdn.brandfetch.io/ELV/w/400/h/400?c=1idopYfmtR7ZKg8QMud Barclays Maintains Overweight on Elevance Health, Raises Price Target to $469 Barclays analyst Andrew Mok has maintained an Overweight rating on Elevance Health (NYSE: ELV) and increased the price target from $457 to $469. This adjustment reflects a positive outlook for the company in the market. https://openbell.ai/news/ZS:1791382377010 2026-10-07T14:12:57.010Z daily 0.9 https://cdn.brandfetch.io/ZS/w/400/h/400?c=1idopYfmtR7ZKg8QMud RBC Capital Reiterates Outperform on Zscaler, Maintains $236 Price Target RBC Capital analyst Matthew Hedberg has reiterated an 'Outperform' rating on Zscaler (NASDAQ: ZS) and maintained a price target of $236 for the stock. This endorsement suggests confidence in Zscaler's performance in the market. https://openbell.ai/news/PENG:1791382283420 2026-10-07T14:11:23.420Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/07/Paris--France---July-9--2026--The-Logo-O.jpg?width=250&height=187 Penguin Solutions Says Agentic AI Is Creating New Memory Boom Penguin Solutions, Inc. reported fourth-quarter revenue of $566.69 million, exceeding estimates of $516.12 million, with adjusted earnings of $1 per share surpassing expectations of 78 cents. The company raised its fiscal 2027 outlook, projecting revenue between $2.25 billion and $2.596 billion, driven by strong demand for AI infrastructure, which accounted for 78% of net sales and grew 141% year-over-year. Following the results, shares surged over 17%, reaching $75.37, as trading volume significantly increased and short interest remained high. https://openbell.ai/news/MRVL:1791382266343 2026-10-07T14:11:06.343Z daily 0.9 https://cdn.brandfetch.io/MRVL/w/400/h/400?c=1idopYfmtR7ZKg8QMud RBC Capital Maintains Outperform on Marvell Technology, Raises Price Target to $425 RBC Capital analyst Srini Pajjuri has maintained an Outperform rating on Marvell Technology (NASDAQ: MRVL) and increased the price target from $360 to $425. This adjustment reflects a positive outlook on the company's performance. https://openbell.ai/news/NVDA:1791382226638 2026-10-07T14:10:26.638Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/07/A-Majestic-Emperor-Penguin-Stands-Gracef.jpg?width=250&height=187 Penguin's Mystery 36,000-GPU Norway Deal Appears to Be Volta's $10B Anthropic AI Project Penguin Solutions Inc. (NASDAQ: PENG) announced a significant project involving 36,000 GPUs in Norway, which aligns with a reported $10 billion deal by Volta Infrastructure for Anthropic. The unnamed cloud infrastructure customer has a $10 billion computing demand from a leading AI lab. Penguin's recent quarterly results showed a 68% revenue increase to $566.7 million, leading to a 15% rise in its stock price. Volta is seeking $5 billion in financing to support this project, with $3.7 billion allocated for the GPUs. https://openbell.ai/news/WHR:1791382141141 2026-10-07T14:09:01.141Z daily 0.9 https://cdn.brandfetch.io/WHR/w/400/h/400?c=1idopYfmtR7ZKg8QMud RBC Capital Maintains Underperform on Whirlpool, Lowers Price Target to $22 RBC Capital analyst Mike Dahl has maintained an 'Underperform' rating on Whirlpool (NYSE: WHR) and has reduced the price target from $32 to $22. This adjustment reflects a bearish outlook on the company's performance in the market. https://openbell.ai/news/BKV:1791382130772 2026-10-07T14:08:50.772Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/07/Display-Of-Stock-Market-Quotes.jpg?width=250&height=187 BKV, Lamb Weston, Penguin Solutions And Other Big Stocks Moving Higher On Wednesday BKV Corp (NYSE:BKV) shares increased by 9.2% to $24.08 following the announcement of an equipment supply contract by a subsidiary. Meanwhile, Lamb Weston Holdings, Inc. (NYSE:LW) rose 2.7% to $49.19 after reporting better-than-expected first-quarter financial results and raising its FY27 guidance above estimates. Overall, U.S. stocks were lower, with the Dow Jones index falling around 1% on the same day. https://openbell.ai/news/DHR:1791382124166 2026-10-07T14:08:44.166Z daily 0.9 https://cdn.brandfetch.io/DHR/w/400/h/400?c=1idopYfmtR7ZKg8QMud Barclays Maintains Overweight on Danaher, Raises Price Target to $255 Barclays analyst Luke Sergott has maintained an Overweight rating on Danaher (NYSE: DHR) and increased the price target from $230 to $255. This adjustment reflects a positive outlook on the company's performance. https://openbell.ai/news/DB:1791382122841 2026-10-07T14:08:42.841Z daily 0.9 https://cdn.brandfetch.io/DB/w/400/h/400?c=1idopYfmtR7ZKg8QMud Shares of U.S.-traded European banks are trading lower as multiple concerns push up bond yields and dampen the economic outlook for the EU and UK, including French debt levels and protests, gains by the AfD party in Germany, and energy-driven inflation. openbell Financial News https://openbell.ai/news/MU:1791381970123 2026-10-07T14:06:10.123Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/07/SP-500-Set-To-Surge-Like-Never-Before-Be.jpg?width=250&height=187 Nvidia, Micron and Other 5 S&P 500 Stocks With +100% Revenue Growth Seven companies in the S&P 500 have reported over 100% revenue growth, with Micron Technology leading at +379.3% in its fiscal fourth quarter of 2026, generating $54.23 billion. Nvidia follows with +105.9% growth, reporting $96.22 billion in revenue for its fiscal second quarter of 2027. Other notable companies include Sandisk (+371.6%) and Bloom Energy (+165.5%). The stock prices of these companies have also seen significant increases, with Sandisk up 580% this year. https://openbell.ai/news/OC:1791381902156 2026-10-07T14:05:02.156Z daily 0.9 https://cdn.brandfetch.io/OC/w/400/h/400?c=1idopYfmtR7ZKg8QMud RBC Capital Downgrades Owens-Corning to Sector Perform, Lowers Price Target to $127 RBC Capital analyst Mike Dahl has downgraded Owens-Corning (NYSE: OC) from Outperform to Sector Perform. The price target for the stock has been reduced from $172 to $127. https://openbell.ai/news/MRVL:1791381887560 2026-10-07T14:04:47.560Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/07/Marvell-Technology-Group-Company---EK.jpg?width=250&height=187 Marvell Just Found Nvidia’s Biggest AI Weak Spot — and It’s a $30 Billion Business Marvell Technology, Inc. (NASDAQ: MRVL) is positioning itself to capture a significant share of the custom-chip market, potentially reaching $30 billion by fiscal 2031. The company expects its custom silicon business, which generated approximately $1.5 billion last year, to exceed $12 billion in fiscal 2029, driven by demand from major U.S. hyperscalers. Marvell's strategic partnership with Nvidia, which includes a $2 billion investment from Nvidia, allows it to provide custom XPUs and networking solutions while integrating with Nvidia's technology. https://openbell.ai/news/GEV:1791381843100 2026-10-07T14:04:03.100Z daily 0.9 https://cdn.brandfetch.io/GEV/w/400/h/400?c=1idopYfmtR7ZKg8QMud Watching GE Vernova; Hearing Investor Business Daily SwingTrader Sells Stock openbell Financial News https://openbell.ai/news/MHK:1791381791682 2026-10-07T14:03:11.682Z daily 0.9 https://cdn.brandfetch.io/MHK/w/400/h/400?c=1idopYfmtR7ZKg8QMud RBC Capital Downgrades Mohawk Industries to Underperform, Lowers Price Target to $112 RBC Capital analyst Mike Dahl has downgraded Mohawk Industries (NYSE: MHK) from Sector Perform to Underperform. The price target for the company's stock has been reduced from $130 to $112. https://openbell.ai/news/SPCX:1791381738526 2026-10-07T14:02:18.526Z daily 0.9 https://cdn.brandfetch.io/SPCX/w/400/h/400?c=1idopYfmtR7ZKg8QMud Reported October 6, FCC Approves SpaceX NGSO MSS System For Direct-To-Device Services On October 6, the Federal Communications Commission (FCC) approved SpaceX's Non-Geostationary Satellite Orbit (NGSO) Mobile Satellite Service (MSS) system, enabling the company to offer direct-to-device services. This approval is a significant step for SpaceX in expanding its satellite communication capabilities. The stock ticker for SpaceX is SPCX. https://openbell.ai/news/CSCO:1791381715939 2026-10-07T14:01:55.939Z daily 0.9 https://cdn.brandfetch.io/CSCO/w/400/h/400?c=1idopYfmtR7ZKg8QMud Cisco Launches Agentic Partnership Cisco (NASDAQ: CSCO) has launched agentic collaboration innovations aimed at enhancing the synergy between people and agents in the workplace. This initiative focuses on three key areas: the evolution of work processes, adaptation of the workplace environment, and improved customer engagement strategies in the context of AI advancements. https://openbell.ai/news/HALO:1791381566199 2026-10-07T13:59:26.199Z daily 0.9 https://cdn.brandfetch.io/HALO/w/400/h/400?c=1idopYfmtR7ZKg8QMud Halozyme Says Dutch Court Upholds Its Patent, Bars Merck From Making And Selling Keytruda SC In Multiple European Markets openbell Financial News https://openbell.ai/news/BLDR:1791381299759 2026-10-07T13:54:59.759Z daily 0.9 https://cdn.brandfetch.io/BLDR/w/400/h/400?c=1idopYfmtR7ZKg8QMud RBC Capital Downgrades Builders FirstSource to Sector Perform, Lowers Price Target to $62 RBC Capital analyst Mike Dahl has downgraded Builders FirstSource (NYSE: BLDR) from Outperform to Sector Perform. The price target for the company's stock has been reduced from $88 to $62. https://openbell.ai/news/HCA:1791381138339 2026-10-07T13:52:18.339Z daily 0.9 https://cdn.brandfetch.io/HCA/w/400/h/400?c=1idopYfmtR7ZKg8QMud RBC Capital Maintains Outperform on HCA Healthcare, Raises Price Target to $496 RBC Capital analyst Ben Hendrix has maintained an 'Outperform' rating on HCA Healthcare (NYSE: HCA) and increased the price target from $435 to $496. This adjustment reflects a positive outlook on the company's performance. https://openbell.ai/news/META:1791381074802 2026-10-07T13:51:14.802Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/07/Meta-Muse.jpg?width=250&height=187 Meta's Muse Could Generate $27 Billion a Year, Citi Says as AI Agent Usage Surges Meta Platforms Inc. (NASDAQ: META) could generate over $27 billion annually from its Muse personal AI agent by 2030, according to Citigroup Inc. The Muse app, launched on September 8, has achieved 6.6 million downloads and 1.8 million daily active users, reaching No. 1 on Apple's U.S. App Store shortly after its launch. Citi's forecast includes approximately $23 billion from transaction-related revenue and $4.5 billion from subscriptions, although Meta faces competition from established players like OpenAI and Google. https://openbell.ai/news/ACI:1791381013137 2026-10-07T13:50:13.137Z daily 0.9 https://cdn.brandfetch.io/ACI/w/400/h/400?c=1idopYfmtR7ZKg8QMud RBC Capital Reiterates Outperform on Albertsons Companies, Maintains $13 Price Target RBC Capital analyst Steven Shemesh has reiterated an 'Outperform' rating on Albertsons Companies (NYSE: ACI) while maintaining a price target of $13. This endorsement suggests confidence in the company's performance and potential for growth in the market. https://openbell.ai/news/CRBG:1791380953033 2026-10-07T13:49:13.033Z daily 0.9 https://cdn.brandfetch.io/CRBG/w/400/h/400?c=1idopYfmtR7ZKg8QMud Barclays Maintains Overweight on Corebridge Financial, Raises Price Target to $39 Barclays analyst Alex Scott has maintained an Overweight rating on Corebridge Financial (NYSE: CRBG) and raised the price target from $33 to $39. This adjustment reflects a positive outlook on the company's performance. https://openbell.ai/news/GMAC:1791380893598 2026-10-07T13:48:13.598Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/07/Benzinga-Quick-Spark.jpg?width=250&height=187 QUICK SPARK: New Simplify ETF Takes Global Macro Approach Beyond 60/40 Portfolio Simplify Asset Management launched the Simplify Brookwood Global Macro ETF (NYSE: GMAC), which offers a flexible global macro strategy that includes exposure to various asset classes such as commodities, energy, and real estate. The ETF, sub-advised by Brookwood Investment Group, allows for both long and short positions and adjusts based on economic factors like inflation and interest rates. GMAC aims to serve as a liquid alternatives building block for investors looking for diversification beyond the traditional 60/40 portfolio. https://openbell.ai/news/CRBU:1791380885047 2026-10-07T13:48:05.047Z daily 0.9 https://cdn.brandfetch.io/CRBU/w/400/h/400?c=1idopYfmtR7ZKg8QMud RBC Capital Downgrades Caribou Biosciences to Sector Perform, Lowers Price Target to $1 RBC Capital analyst Luca Issi has downgraded Caribou Biosciences (NASDAQ: CRBU) from Outperform to Sector Perform. The price target for the stock has been significantly reduced from $10 to $1. https://openbell.ai/news/MRVL:1791380874254 2026-10-07T13:47:54.254Z daily 0.9 https://cdn.brandfetch.io/MRVL/w/400/h/400?c=1idopYfmtR7ZKg8QMud Piper Sandler Maintains Overweight on Marvell Technology, Raises Price Target to $400 Piper Sandler analyst David O'Connor has maintained an Overweight rating on Marvell Technology (NASDAQ: MRVL) and raised the price target from $270 to $400. This adjustment reflects a positive outlook for the company. https://openbell.ai/news/PARA:1791380778363 2026-10-07T13:46:18.363Z daily 0.9 https://cdn.brandfetch.io/PARA/w/400/h/400?c=1idopYfmtR7ZKg8QMud EXCLUSIVE: Parabolic Announces Preliminary Q3 2026 Revenue of $4.7M, +65% Y/Y, +106% Q/Q; Full Results Out On Nov 16. openbell Financial News https://openbell.ai/news/RCKT:1791380752045 2026-10-07T13:45:52.045Z daily 0.9 https://cdn.brandfetch.io/RCKT/w/400/h/400?c=1idopYfmtR7ZKg8QMud Rocket Pharmaceuticals Reports Key Data, Development Milestones Demonstrated During Danon Disease Investor Webinar For Its Pivotal Phase 2 Study In Participants Treated Under Modified Protocol Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) provided updates during its October 6 investor webinar regarding its pivotal Phase 2 study for Danon disease. The company reported sustained biological activity from longer-term Phase 1 follow-up and initial safety observations in the first three patients treated under a modified protocol. The updates indicate a defined path toward completing the FDA-aligned trial. https://openbell.ai/news/PARA:1791380710095 2026-10-07T13:45:10.095Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/07/Investors-Show-Virtual-Screen-Stock-Mark.jpg?width=250&height=187 EXCLUSIVE: Parabolic Revenue Jumps 106% Sequentially With First ConnectAndSell Contribution Banzai International, Inc. (NASDAQ: PARA), operating as Parabolic, anticipates a preliminary third-quarter revenue of approximately $4.7 million, reflecting a 106% sequential growth from $2.3 million in Q2 and a 65% increase year-over-year. This growth is partly attributed to the first contribution from its recently acquired ConnectAndSell business, which was acquired for $13.2 million in July. The company also announced expected annualized cost savings of $9.3 million from the integration of ConnectAndSell and a business-unit realignment, aiming to enhance profitability and cash flow by 2027. Despite these positive developments, shares of Banzai International were down 7.85% in premarket trading. https://openbell.ai/news/MSFT:1791380653477 2026-10-07T13:44:13.477Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/07/The-Logo-Of-An-American-Technology-Compa.jpg?width=250&height=187 Nvidia Inside: Microsoft's New Laptop Runs AI Agents Without the Cloud Microsoft is launching the Surface Laptop Ultra, which utilizes Nvidia's RTX Spark chips to run AI agents directly on the device rather than relying on cloud computing. This move aims to shift some workloads from Microsoft's Azure data centers to high-powered Windows PCs. The collaboration between Microsoft CEO Satya Nadella and Nvidia CEO Jensen Huang will be showcased at a San Francisco event. The introduction of this laptop comes amid rising PC prices due to a memory-chip shortage, which has also affected Nvidia's pricing for its AI desktop. https://openbell.ai/news/LNG:1791380639028 2026-10-07T13:43:59.028Z daily 0.9 https://cdn.brandfetch.io/LNG/w/400/h/400?c=1idopYfmtR7ZKg8QMud Barclays Maintains Overweight on Cheniere Energy, Raises Price Target to $287 Barclays analyst Theresa Chen has maintained an Overweight rating on Cheniere Energy (NYSE: LNG) and increased the price target from $279 to $287. This adjustment reflects a positive outlook for the company's stock performance. https://openbell.ai/news/ZS:1791380554552 2026-10-07T13:42:34.552Z daily 0.9 https://cdn.brandfetch.io/ZS/w/400/h/400?c=1idopYfmtR7ZKg8QMud TD Cowen Maintains Buy on Zscaler, Raises Price Target to $230 TD Cowen analyst Shaul Eyal has maintained a Buy rating on Zscaler (NASDAQ: ZS) and increased the price target from $200 to $230. This adjustment reflects a positive outlook on the company's performance. https://openbell.ai/news/COSM:1791380413438 2026-10-07T13:40:13.438Z daily 0.9 https://cdn.brandfetch.io/COSM/w/400/h/400?c=1idopYfmtR7ZKg8QMud Cosmos Health FY2026 Revenue expected to be more than $90.000M vs $84.300M Est Cosmos Health (NASDAQ: COSM) has announced that its revenue for FY2026 is expected to exceed $90 million, surpassing the previous estimate of $84.3 million. This positive outlook indicates a stronger financial performance than initially anticipated.